alliantgroup

The New Biotech Credit: Getting Your Application on Top of the Pile

In a just-published article in Practical Tax Strategies (July 2010), alliantgroup’s Dean Zerbe and David Ji explain the unique nature of the biotech credit/grant and what it's going to take to make sure your application measures up.

The article is available online now (click HERE) by subscription or in July when the print edition is distributed.

Treasury Guidance on The New Biotech Research Credit

New "Qualifying Therapeutic Discovery Project Credit" provides biotechs with much-needed capital to sustain their R&D programs. New Guidance from Treasury is now available.
learn more >>


	IRS Liens & Levies on Small Business Can be a Job Killer, alliantgroup Warns (07-28-10) more >> alliantgroup Adds R&D Tax Expert to Growing Team: Greg Knarr Joins as Director in Indiana Office (07-26-10) more >> Senator Chuck Grassley Visits alliantgroup (06-18-10) more >> alliantgroup Bolsters Top Tax Talent With Congressman Jim Ramstad (6-2-10) more >> IRS Switches Audits From Large Corporations to Small Business – Hurting Economic Recovery (4-12-10) more >> Health Reform Package Includes New Biotech Research Credit (3-26-10) more >> Senate Passes Tax Extenders, Including R&D Tax Credit (3-11-10) more >> Another Taxpayer R&D Victory at the Courthouse! (2-4-10) more >>






	Dean Zerbe Former Tax Counsel, Senate Finance Committee _____________________ Forbes.com: Good News, At Last, On Small-Business Taxes Forbes.com: The Big Tax Increase Facing Small Business Forbes.com: IRS Audits Small Biz More, Big Guys Less Forbes.com: Health Reform Will Set Off Biotech Tax Credit Rush Forbes.com: Small Business Needs IRS Relief Forbes.com: The President’s Tax Proposals: A Reality Check Looking for Dean Zerbe? You’ll find him in your corner